Abdulrahman Alshammari Selected Research

purmorphamine

3/2022

Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive Disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abdulrahman Alshammari Research Topics

Disease

4	Inflammation (Inflammations) 04/2022 - 08/2020
3	Neoplasms (Cancer) 04/2022 - 08/2021
2	Infections 04/2022 - 03/2022
2	Parkinson Disease (Parkinson's Disease) 04/2022 - 01/2022
2	COVID-19 09/2021 - 02/2021
1	Demyelinating Diseases (Demyelinating Disease) 06/2022
1	Insulin Resistance 06/2022
1	Whipple Disease (Whipple's Disease) 04/2022
1	Obesity 04/2022
1	Coronary Disease (Coronary Heart Disease) 04/2022
1	Weight Gain 04/2022
1	Septic Shock (Toxic Shock Syndrome) 04/2022
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 03/2022
1	Malocclusion (Crossbite) 03/2022
1	Autistic Disorder (Autism) 01/2022
1	Huntington Disease (Huntington's Disease) 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Schizophrenia (Dementia Praecox) 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Mucormycosis 09/2021
1	Hematologic Neoplasms (Hematological Malignancy) 08/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Wounds and Injuries (Trauma) 08/2020
1	Kidney Neoplasms (Kidney Cancer) 08/2020

Drug/Important Bio-Agent (IBA)

4	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 08/2021
3	AntioxidantsIBA 04/2022 - 08/2021
2	Myelin Basic ProteinIBA 06/2022 - 01/2022
2	LipidsIBA 04/2022 - 09/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2022 - 08/2021
2	Neuroprotective AgentsIBA 03/2022 - 01/2022
1	4-hydroxyisoleucineIBA 06/2022
1	Amino Acids FDA Link 06/2022
1	Insulin (Novolin)FDA Link 06/2022
1	Peptides (Polypeptides)IBA 04/2022
1	VaccinesIBA 04/2022
1	beta-LactamsIBA 04/2022
1	Tetracycline (Achromycin)FDA LinkGeneric 04/2022
1	CholesterolIBA 04/2022
1	Triglycerides (Triacylglycerol)IBA 04/2022
1	LDL CholesterolIBA 04/2022
1	geraniol (nerol)IBA 04/2022
1	Virulence Factors (Pathogenicity Factors)IBA 04/2022
1	Panton-Valentine leukocidinIBA 04/2022
1	tofacitinibIBA 04/2022
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2022
1	Janus Kinase InhibitorsIBA 04/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2022
1	purmorphamineIBA 03/2022
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 03/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	pregna-4,17-diene-3,16-dione (guggulsterone)IBA 01/2022
1	propionic acid (potassium propionate)IBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	PPAR gammaIBA 01/2022
1	butinIBA 01/2022
1	mangostinIBA 01/2022
1	Freund's AdjuvantIBA 01/2022
1	Amphotericin B (Amphotericin)FDA LinkGeneric 09/2021
1	AnthracyclinesIBA 08/2021
1	Diosmin (Daflon)IBA 08/2021
1	Estrogen ReceptorsIBA 01/2021
1	Estrogen Receptor alphaIBA 01/2021
1	RivaroxabanIBA 08/2020
1	Pharmaceutical PreparationsIBA 08/2020
1	Sunitinib (Sutent)FDA Link 08/2020

Therapy/Procedure

1	Bite Force (Occlusal Forces) 03/2022
1	Injections 01/2022
1	Debridement 09/2021
1	Therapeutics 02/2021